Clinical Trials Browser

Phase 2/3 × Completed × Magnetic Resonance Spectroscopy × Clear all

NCT04396860 2026-03-05

Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma

Phase 2/3 Completed

159 enrolled 17 charts

Gliosarcoma

NCT02624518 2023-04-10

68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer

Phase 2/3 Completed

122 enrolled 8 charts

Prostate Adenocarcinoma

NCT02678351 2022-03-04

68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery

Phase 2/3 Completed

74 enrolled 9 charts

Stage II Prostate Adenocarcinoma

NCT02673151 2022-01-13

68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment

Phase 2/3 Completed

61 enrolled 10 charts

Prostatic Neoplasms

NCT01379183 2016-03-21

Using Magnetic Resonance (MR) to Understand the Effect of Erythromycin on Bowel Motility

Phase 2/3 Completed

40 enrolled 10 charts

Multiple Endocrine Neoplasia Type 1

NCT00123760 2016-02-25

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

Phase 2/3 Completed

10,838 enrolled

CNSGastrointestinalHead & NeckLymphoidThoracic

Brain Neoplasms, Lung Neoplasms, Lymphoma, Thyroid Neoplasms, Colorectal Neoplasms

NCT00002930 2013-01-18

PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery

Phase 2/3 Completed

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms